Tuesday, November 17, 2026 Vol. I · No. 5
Business · Via MarketWatch

Summit Therapeutics’ stock tumbles again as FDA recommends new trial for lung-cancer drug

Image: MarketWatch

The U.S. regulator’s disclosure was more extensive than what the biotech company had announced Sunday.

This is a brief. The reporting belongs to MarketWatch — read the complete story, with full context and credits, at the source.

Read the full story at MarketWatch ↗

marketwatch.com

More from the Business desk